<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2023-1-110-118</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-1964</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL STUDIES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group></article-categories><title-group><article-title>Chondroprotectors as modulators of neuroinflammation</article-title><trans-title-group xml:lang="ru"><trans-title>Хондропротекторы как модуляторы нейровоспаления</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119333, Москва, ул. Вавилова, 44, корп. 2</p></bio><bio xml:lang="en"><p>119333, Moscow, Vavilov St., 44, Build. 2</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Алексеевна Громова</p><p>119333, Москва, ул. Вавилова, 44, корп. 2</p></bio><bio xml:lang="en"><p>Olga Alekseevna Gromova</p><p>119333, Moscow, Vavilov St., 44, Build. 2</p></bio><email xlink:type="simple">unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1314-2887</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Назаренко</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Nazarenko</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>127299, Москва, ул. Приорова, 10</p></bio><bio xml:lang="en"><p>127299, Moscow, Priorova St., 10</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральный исследовательский центр «Информатика и управление» Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Pharmacoinformatics of the Federal Research Center “Computer Science and Management”, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр травматологии и ортопедии им. Н.Н. Приорова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Priorov National Medical Research Center of Traumatology and Orthopedics</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>19</day><month>02</month><year>2023</year></pub-date><volume>15</volume><issue>1</issue><fpage>110</fpage><lpage>118</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Torshin I.Y., Gromova O.A., Nazarenko A.G., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Торшин И.Ю., Громова О.А., Назаренко А.Г.</copyright-holder><copyright-holder xml:lang="en">Torshin I.Y., Gromova O.A., Nazarenko A.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/1964">https://nnp.ima-press.net/nnp/article/view/1964</self-uri><abstract><p>Modern fundamental and clinical studies show that chondroprotector molecules (chondroitin sulfate – CS; glucosamine sulfate – GS) can be useful in the treatment of neuroinflammation and so-called "inflammageing" – chronic, low-grade systemic inflammation that stimulates the development of neurodegeneration, atherosclerosis, ischemia, osteoarthritis and other pathologies. The role of CS and GS in the central nervous system are evident in the context of the concepts of the tetrapartite synapse and perineuronal nets (PNNs). Molecular mechanisms of action of CS and GS on neuroinflammation include: 1) interaction with the CD44 receptor, leading to inhibition of the pro-inflammatory factor NFκB, antiatherosclerotic and anticoagulant effects; 2) direct contribution to the formation of the PNNs, which support the division and differentiation of neurons; 3) inhibition of Toll-like receptors; 4) antioxidant and neuroprotective properties through activation of the PKC/PI3K/Akt signaling pathway; 5) inhibition of matrix metalloproteinases. These molecular effects determine the neuroprotective properties of CS/GS in ischemia, neurodegeneration, and pain syndromes associated with neuroinflammation.</p></abstract><trans-abstract xml:lang="ru"><p>Современные фундаментальные и клинические исследования показывают, что молекулы хондропротекторов (хондроитина сульфата – ХС; глюкозамина сульфата – ГС) могут быть полезны в терапии нейровоспаления и так называемого «инфламейджинга» – хронического, вялотекущего системного воспаления, стимулирующего развитие нейродегенерации, атеросклероза, ишемии, остеоартрита и других патологий. Роли ХС и ГС в центральной нервной системе очевидны в свете концепций четырехкомпонентного синапса и перинейрональных сетей (ПНС). Молекулярные механизмы действия ХС и ГС на нейровоспаление включают: 1) взаимодействие с рецептором CD44, приводящее к ингибированию провоспалительного фактора NF-κВ, антиатеросклеротическому и антикоагулянтному эффектам; 2) прямое участие в формировании ПНС, поддерживающих деление и дифференцировку нейронов; 3) ингибирование толл-подобных рецепторов; 4) антиоксидантные и нейропротекторные свойства посредством активации сигнального пути PKC/PI3K/Akt; 5) ингибирование матриксных металлопротеиназ. Эти молекулярные эффекты обусловливают нейропротекторные свойства ХС/ГС при ишемии, нейродегенерации и при болевых синдромах, связанных с нейровоспалением.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>нейровоспаление</kwd><kwd>боль</kwd><kwd>нейродегенерация</kwd><kwd>ишемия</kwd><kwd>Хондрогард</kwd></kwd-group><kwd-group xml:lang="en"><kwd>neuroinflammation</kwd><kwd>pain</kwd><kwd>neurodegeneration</kwd><kwd>ischemia</kwd><kwd>Chondroguard</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Расчеты выполнены по государственному заданию № 0063-2019-0003 «Математические методы анализа данных и прогнозирования» с использованием инфраструктуры Центра коллективного пользования «Высокопроизводительные вычисления и большие данные» ФИЦ «Информатика и управление» РАН. Статья опубликована при поддержке компании ЗАО «ФармФирма «Сотекс».</funding-statement><funding-statement xml:lang="en">Publication of this article has been supported by Sotex PharmFirma.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Сарвилина ИВ, Лила АМ, Громова ОА, Торшин ИЮ. Анализ механизмов развития нейроревматологических последствий COVID-19 и возможности их фармакологической коррекции. Современная ревматология. 2022;16(2):92-8. doi:10.14412/1996-7012-2022-2-92-98</mixed-citation><mixed-citation xml:lang="en">Sarvilina IV, Lila AM, Gromova OA, Torshin IYu. Analysis of the mechanisms of development of neurorheumatological consequences of COVID-19 and the possibility of their pharmacological correction. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2022;16(2):92-8. doi:10.14412/1996-7012-2022-2-92-98 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин ИЮ, Громова ОА, Лила АМ и др. Результаты постгеномного анализа молекулы глюкозамина сульфата указывают на перспективы лечения коморбидных заболеваний. Современная ревматология. 2018;12(4):129-36. doi:10.14412/1996-7012-2018-4-129-136</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Gromova OA, Lila AM, et al. The results of postgenomic analysis of a glucosamine sulfate molecule indicate theprospects of treatment for comorbidities. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2018;12(4):129-36. doi:10.14412/1996-7012-2018-4-129-136 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Громова ОА, Торшин ИЮ, Семенов ВА и др. О неврологических ролях хондроитина сульфата и глюкозамина сульфата: систематический анализ. Неврология, нейропсихиатрия, психосоматика. 2019;11(3):137-43. doi:10.14412/2074-2711-2019-3-137-143</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Semenov VA, et al. On the neurological roles of chondroitin sulfate and glucosamine sulfate: a systematic analysis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):137-43. doi:10.14412/2074-2711-2019-3-137-143 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gromova OA, Torshin IYu, Semenov VA, et al. On the neurological roles of chondroitin sulfate and glucosamine sulfate: a systematic analysis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):137-43. doi:10.14412/2074-2711-2019-3-137-143 (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Chelini G, Pantazopoulos H, Durning P, Berretta S. The tetrapartite synapse: a key concept in the pathophysiology of schizophrenia. Eur Psychiatry. 2018 Apr;50:60-9. doi:10.1016/j.eurpsy.2018.02.003. Epub 2018 Mar 2.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Canning DR, Brelsford NR, Lovett NW. Chondroitin sulfate effects on neural stem cell differentiation. In Vitro Cell Dev Biol Anim. 2016 Jan;52(1):35-44. doi:10.1007/s11626-015-9941-8</mixed-citation><mixed-citation xml:lang="en">Canning DR, Brelsford NR, Lovett NW. Chondroitin sulfate effects on neural stem cell differentiation. In Vitro Cell Dev Biol Anim. 2016 Jan;52(1):35-44. doi:10.1007/s11626-015-9941-8</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Dyck SM, Karimi-Abdolrezaee S. Chondroitin sulfate proteoglycans: Key modulators in the developing and pathologic central nervous system. Exp Neurol. 2015 Jul;269:169-87. doi:10.1016/j.expneurol.2015.04.006</mixed-citation><mixed-citation xml:lang="en">Dyck SM, Karimi-Abdolrezaee S. Chondroitin sulfate proteoglycans: Key modulators in the developing and pathologic central nervous system. Exp Neurol. 2015 Jul;269:169-87. doi:10.1016/j.expneurol.2015.04.006</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Белова ОВ, Арефьева ТИ, Москвина СН. Иммуновоспалительные аспекты болезни Паркинсона. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(2):110-9. doi:10.17116/jnevro2020120021110</mixed-citation><mixed-citation xml:lang="en">Belova OV, Aref'eva TI, Moskvina SN. Immunological aspects of Parkinson's disease. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2020;120(2):110-9. doi:10.17116/jnevro2020120021110 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ghorbani S, Yong VW. The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis. Brain. 2021 Aug 17;144(7):1958-73. doi:10.1093/brain/awab059</mixed-citation><mixed-citation xml:lang="en">Ghorbani S, Yong VW. The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis. Brain. 2021 Aug 17;144(7):1958-73. doi:10.1093/brain/awab059</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jang DG, Sim HJ, Song EK, et al. Extracellular matrixes and neuroinflammation. BMB Rep. 2020 Nov;53(10):491-9. doi:10.5483/BMBRep.2020.53.10.156</mixed-citation><mixed-citation xml:lang="en">Jang DG, Sim HJ, Song EK, et al. Extracellular matrixes and neuroinflammation. BMB Rep. 2020 Nov;53(10):491-9. doi:10.5483/BMBRep.2020.53.10.156</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bosiacki M, Gassowska-Dobrowolska M, Kojder K, et al. Perineuronal Nets and Their Role in Synaptic Homeostasis. Int J Mol Sci. 2019 Aug 22;20(17):4108. doi:10.3390/ijms20174108</mixed-citation><mixed-citation xml:lang="en">Bosiacki M, Gassowska-Dobrowolska M, Kojder K, et al. Perineuronal Nets and Their Role in Synaptic Homeostasis. Int J Mol Sci. 2019 Aug 22;20(17):4108. doi:10.3390/ijms20174108</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Canas N, Gorina R, Planas AM, et al. Chondroitin sulfate inhibits lipopolysaccharideinduced inflammation in rat astrocytes by preventing nuclear factor kappa B activation. Neuroscience. 2010 May 19;167(3):872-9. doi:10.1016/j.neuroscience.2010.02.069</mixed-citation><mixed-citation xml:lang="en">Canas N, Gorina R, Planas AM, et al. Chondroitin sulfate inhibits lipopolysaccharideinduced inflammation in rat astrocytes by preventing nuclear factor kappa B activation. Neuroscience. 2010 May 19;167(3):872-9. doi:10.1016/j.neuroscience.2010.02.069</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Лила АМ, Торшин ИЮ, Громова ОА. Стоит ли переосмыслить полученный полвека назад положительный опыт применения хондроитинсульфатов при атеросклерозе? ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2020;13(2):184-91. doi:10.17749/2070-4909/farmakoekonomika.2020.043</mixed-citation><mixed-citation xml:lang="en">Lila AM, Torshin IYu, Gromova OA. Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis? FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020;13(2):184-91. doi:10.17749/2070-4909/farmakoekonomika.2020.043 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин ИЮ, Лила АМ, Громова ОА и др. Антикоагулянтные и антиагрегантные эффекты хондроитина сульфата. РМЖ. 2020;(7):44-8.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Lila AM, Gromova OA, et al. Anticoagulant and antiplatelet effects of chondroitin sulfate. RMJ. 2020;(7):44-8 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Yamada J, Maeda S, Soya M, et al. Alleviation of cognitive deficits via upregulation of chondroitin sulfate biosynthesis by lignan sesamin in a mouse model of neuroinflammation. J Nutr Biochem. 2022 Oct;108:109093. doi:10.1016/j.jnutbio.2022.109093</mixed-citation><mixed-citation xml:lang="en">Yamada J, Maeda S, Soya M, et al. Alleviation of cognitive deficits via upregulation of chondroitin sulfate biosynthesis by lignan sesamin in a mouse model of neuroinflammation. J Nutr Biochem. 2022 Oct;108:109093. doi:10.1016/j.jnutbio.2022.109093</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">McCrary MR, Jiang MQ, Jesson K, et al. Glycosaminoglycan scaffolding and neural progenitor cell transplantation promotes regenerative immunomodulation in the mouse ischemic brain. Exp Neurol. 2022 Nov;357:114177. doi:10.1016/j.expneurol.2022.114177. Epub 2022 Jul 20.</mixed-citation><mixed-citation xml:lang="en">McCrary MR, Jiang MQ, Jesson K, et al. Glycosaminoglycan scaffolding and neural progenitor cell transplantation promotes regenerative immunomodulation in the mouse ischemic brain. Exp Neurol. 2022 Nov;357:114177. doi:10.1016/j.expneurol.2022.114177. Epub 2022 Jul 20.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Yao M, Fang J, Li J, et al. Modulation of the proteoglycan receptor PTPσ promotes white matter integrity and functional recovery after intracerebral hemorrhage stroke in mice. J Neuroinflammation. 2022 Aug 18;19(1):207. doi:10.1186/s12974-022-02561-4</mixed-citation><mixed-citation xml:lang="en">Yao M, Fang J, Li J, et al. Modulation of the proteoglycan receptor PTPσ promotes white matter integrity and functional recovery after intracerebral hemorrhage stroke in mice. J Neuroinflammation. 2022 Aug 18;19(1):207. doi:10.1186/s12974-022-02561-4</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Karumbaiah L, Enam SF, Brown AC, et al. Chondroitin Sulfate Glycosaminoglycan Hydrogels Create Endogenous Niches for Neural Stem Cells. Bioconjug Chem. 2015 Dec 16;26(12):2336-49. doi:10.1021/acs.bioconjchem.5b00397</mixed-citation><mixed-citation xml:lang="en">Karumbaiah L, Enam SF, Brown AC, et al. Chondroitin Sulfate Glycosaminoglycan Hydrogels Create Endogenous Niches for Neural Stem Cells. Bioconjug Chem. 2015 Dec 16;26(12):2336-49. doi:10.1021/acs.bioconjchem.5b00397</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rauvala H, Paveliev M, Kuja-Panula J, Kulesskaya N. Inhibition and enhancement of neural regeneration by chondroitin sulfate proteoglycans. Neural Regen Res. 2017 May;12(5):687-91. doi:10.4103/1673-5374.206630</mixed-citation><mixed-citation xml:lang="en">Rauvala H, Paveliev M, Kuja-Panula J, Kulesskaya N. Inhibition and enhancement of neural regeneration by chondroitin sulfate proteoglycans. Neural Regen Res. 2017 May;12(5):687-91. doi:10.4103/1673-5374.206630</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Y, Sheng W, Chen L, et al. Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell. 2004 May;15(5):2093-104. doi:10.1091/mbc.e03-09-0667</mixed-citation><mixed-citation xml:lang="en">Wu Y, Sheng W, Chen L, et al. Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell. 2004 May;15(5):2093-104. doi:10.1091/mbc.e03-09-0667</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Liu C, Fan L, Xing J, et al. Inhibition of astrocytic differentiation of transplanted neural stem cells by chondroitin sulfate methacrylate hydrogels for the repair of injured spinal cord. Biomater Sci. 2019 Apr 23;7(5):1995-2008. doi:10.1039/c8bm01363b</mixed-citation><mixed-citation xml:lang="en">Liu C, Fan L, Xing J, et al. Inhibition of astrocytic differentiation of transplanted neural stem cells by chondroitin sulfate methacrylate hydrogels for the repair of injured spinal cord. Biomater Sci. 2019 Apr 23;7(5):1995-2008. doi:10.1039/c8bm01363b</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Betancur MI, Mason HD, Alvarado-Velez M, et al. Chondroitin Sulfate Glycosaminoglycan Matrices Promote Neural Stem Cell Maintenance and Neuroprotection Post-Traumatic Brain Injury. ACS Biomater Sci Eng. 2017 Mar 13;3(3):420-30. doi:10.1021/acsbiomaterials.6b00805</mixed-citation><mixed-citation xml:lang="en">Betancur MI, Mason HD, Alvarado-Velez M, et al. Chondroitin Sulfate Glycosaminoglycan Matrices Promote Neural Stem Cell Maintenance and Neuroprotection Post-Traumatic Brain Injury. ACS Biomater Sci Eng. 2017 Mar 13;3(3):420-30. doi:10.1021/acsbiomaterials.6b00805</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин ИЮ, Громова ОА, Лила АМ и др. Толл-подобные рецепторы как компонент патофизиологии остеоартрита: противовоспалительное, анальгетическое и нейропротекторное действие. Неврология, нейропсихиатрия, психосоматика. 2021;13(4):123-9. doi:10.14412/2074-2711-2021-4-123-129</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Gromova OA, Lila AM, et al. Toll-like receptors as a part of osteoarthritis pathophysiology: anti-inflammatory, analgesic and neuroprotective effects. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021;13(4):123-9. doi:10.14412/2074-2711-2021-4-123-129 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao N, Wu L, Zhang X, et al. Low molecular weight chondroitin sulfate ameliorates pathological changes in 5XFAD mice by improving various functions in the brain. Neuropharmacology. 2021 Nov 1;199:108796. doi:10.1016/j.neuropharm.2021.108796</mixed-citation><mixed-citation xml:lang="en">Zhao N, Wu L, Zhang X, et al. Low molecular weight chondroitin sulfate ameliorates pathological changes in 5XFAD mice by improving various functions in the brain. Neuropharmacology. 2021 Nov 1;199:108796. doi:10.1016/j.neuropharm.2021.108796</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Alfonso-Loeches S, Pascual M, Gomez-Pinedo U, et al. Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse. Glia. 2012 May;60(6):948-64. doi:10.1002/glia.22327</mixed-citation><mixed-citation xml:lang="en">Alfonso-Loeches S, Pascual M, Gomez-Pinedo U, et al. Toll-like receptor 4 participates in the myelin disruptions associated with chronic alcohol abuse. Glia. 2012 May;60(6):948-64. doi:10.1002/glia.22327</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Calamia V, Lourido L, Fernandez-Puente P, et al. Secretome analysis of chondroitin sulfatetreated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties. Arthritis Res Ther. 2012 Oct 2;14(5):R202. doi:10.1186/ar4040</mixed-citation><mixed-citation xml:lang="en">Calamia V, Lourido L, Fernandez-Puente P, et al. Secretome analysis of chondroitin sulfatetreated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties. Arthritis Res Ther. 2012 Oct 2;14(5):R202. doi:10.1186/ar4040</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cauwe B, van den Steen PE, Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol. 2007 MayJun;42(3):113-85. doi:10.1080/10409230701340019</mixed-citation><mixed-citation xml:lang="en">Cauwe B, van den Steen PE, Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol. 2007 MayJun;42(3):113-85. doi:10.1080/10409230701340019</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Shingleton WD, Hodges DJ, Brick P, Cawston TE. Collagenase: a key enzyme in collagen turnover. Biochem Cell Biol. 1996;74(6):759-75. doi:10.1139/o96-083</mixed-citation><mixed-citation xml:lang="en">Shingleton WD, Hodges DJ, Brick P, Cawston TE. Collagenase: a key enzyme in collagen turnover. Biochem Cell Biol. 1996;74(6):759-75. doi:10.1139/o96-083</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Лила АМ, Громова ОА, Торшин ИЮ и др. Молекулярные эффекты хондрогарда при остеоартрите и грыжах межпозвоночного диска. Неврология, нейропсихиатрия, психосоматика. 2017;9(3):88-97. doi:10.14412/2074-2711-2017-3-88-97</mixed-citation><mixed-citation xml:lang="en">Lila AM, Gromova OA, Torshin IYu, et al. Molecular effects of chondroguard in osteoarthritis and herniated discs. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(3):88-97. doi:10.14412/2074-2711-2017-3-88-97 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Martin-de-Saavedra MD, del Barrio L, Canas N, et al. Chondroitin sulfate reduces cell death of rat hippocampal slices subjected to oxygen and glucose deprivation by inhibiting p38, NFkappaB and iNOS. Neurochem Int. 2011 May;58(6):676-83. doi:10.1016/j.neuint.2011.02.006</mixed-citation><mixed-citation xml:lang="en">Martin-de-Saavedra MD, del Barrio L, Canas N, et al. Chondroitin sulfate reduces cell death of rat hippocampal slices subjected to oxygen and glucose deprivation by inhibiting p38, NFkappaB and iNOS. Neurochem Int. 2011 May;58(6):676-83. doi:10.1016/j.neuint.2011.02.006</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Egea J, Garcia AG, Verges J, et al. Antioxidant, antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans. Osteoarthritis Cartilage. 2010 Jun;18 Suppl 1:S24-7. doi:10.1016/j.joca.2010.01.016</mixed-citation><mixed-citation xml:lang="en">Egea J, Garcia AG, Verges J, et al. Antioxidant, antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans. Osteoarthritis Cartilage. 2010 Jun;18 Suppl 1:S24-7. doi:10.1016/j.joca.2010.01.016</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Chen R, Gong P, Tao T, et al. O-GlcNAc Glycosylation of nNOS Promotes Neuronal Apoptosis Following Glutamate Excitotoxicity. Cell Mol Neurobiol. 2017 Nov;37(8):1465-75. doi:10.1007/s10571-017-0477-1</mixed-citation><mixed-citation xml:lang="en">Chen R, Gong P, Tao T, et al. O-GlcNAc Glycosylation of nNOS Promotes Neuronal Apoptosis Following Glutamate Excitotoxicity. Cell Mol Neurobiol. 2017 Nov;37(8):1465-75. doi:10.1007/s10571-017-0477-1</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Fluri F, Grunstein D, Cam E, et al. Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats. Exp Neurol. 2015 Mar;265:142-51. doi:10.1016/j.expneurol.2015.01.005</mixed-citation><mixed-citation xml:lang="en">Fluri F, Grunstein D, Cam E, et al. Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats. Exp Neurol. 2015 Mar;265:142-51. doi:10.1016/j.expneurol.2015.01.005</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Hwang SY, Shin JH, Hwang JS, et al. Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury. Glia. 2010 Nov 15;58(15):1881-92. doi:10.1002/glia.21058</mixed-citation><mixed-citation xml:lang="en">Hwang SY, Shin JH, Hwang JS, et al. Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury. Glia. 2010 Nov 15;58(15):1881-92. doi:10.1002/glia.21058</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Jhelum P, Radhakrishnan M, Paul ARS, et al. Neuroprotective and Proneurogenic Effects of Glucosamine in an Internal Carotid Artery Occlusion Model of Ischemia. Neuromolecular Med. 2022 Sep;24(3):268-73. doi:10.1007/s12017-021-08697-5</mixed-citation><mixed-citation xml:lang="en">Jhelum P, Radhakrishnan M, Paul ARS, et al. Neuroprotective and Proneurogenic Effects of Glucosamine in an Internal Carotid Artery Occlusion Model of Ischemia. Neuromolecular Med. 2022 Sep;24(3):268-73. doi:10.1007/s12017-021-08697-5</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Q, Li J, Liu C, et al. Protective effects of low molecular weight chondroitin sulfate on amyloid beta (Abeta)-induced damage in vitro and in vivo. Neuroscience. 2015 Oct 1;305:169-82. doi:10.1016/j.neuroscience.2015.08.002</mixed-citation><mixed-citation xml:lang="en">Zhang Q, Li J, Liu C, et al. Protective effects of low molecular weight chondroitin sulfate on amyloid beta (Abeta)-induced damage in vitro and in vivo. Neuroscience. 2015 Oct 1;305:169-82. doi:10.1016/j.neuroscience.2015.08.002</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Wang G, Zhou HH, Luo L, et al. Voluntary wheel running is capable of improving cognitive function only in the young but not the middleaged male APPSwe/PS1De9 mice. Neurochem Int. 2021 May;145:105010. doi:10.1016/j.neuint.2021.105010</mixed-citation><mixed-citation xml:lang="en">Wang G, Zhou HH, Luo L, et al. Voluntary wheel running is capable of improving cognitive function only in the young but not the middleaged male APPSwe/PS1De9 mice. Neurochem Int. 2021 May;145:105010. doi:10.1016/j.neuint.2021.105010</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Nemoto W, Yamada K, Nakagawasai O, et al. Effect of repeated oral administration of chondroitin sulfate on neuropathic pain induced by partial sciatic nerve ligation in mice. J Pharmacol Sci. 2018 Aug;137(4):403-6. doi:10.1016/j.jphs.2018.03.003. Epub 2018 Mar 23.</mixed-citation><mixed-citation xml:lang="en">Nemoto W, Yamada K, Nakagawasai O, et al. Effect of repeated oral administration of chondroitin sulfate on neuropathic pain induced by partial sciatic nerve ligation in mice. J Pharmacol Sci. 2018 Aug;137(4):403-6. doi:10.1016/j.jphs.2018.03.003. Epub 2018 Mar 23.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Nemoto W, Yamada K, Ogata Y, et al. Chondroitin sulfate attenuates formalininduced persistent tactile allodynia. J Pharmacol Sci. 2016 Aug;131(4):275-8. doi:10.1016/j.jphs.2016.07.009</mixed-citation><mixed-citation xml:lang="en">Nemoto W, Yamada K, Ogata Y, et al. Chondroitin sulfate attenuates formalininduced persistent tactile allodynia. J Pharmacol Sci. 2016 Aug;131(4):275-8. doi:10.1016/j.jphs.2016.07.009</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Самарцев ИН, Живолупов СА, Баранцевич ЕР, Данилов АБ. Оценка терапевтической эффективности Алфлутопа в комплексном лечении пациентов с хронической болью в нижней части спины (наблюдательное исследование ЦЕЙТНОТ). Журнал неврологии и психиатрии им. С.С. Корсакова. 2021;121(2):24-30. doi:10.17116/jnevro202112102124</mixed-citation><mixed-citation xml:lang="en">Samartcev IN, Zhivolupov SA, Barantsevich ER, Danilov AB. The evaluation of the efficacy of Alflutop in the complex treatment of patients with chronic lower back pain (the observational study ZEITNOT). Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2021;121(2):24-30. doi:10.17116/jnevro202112102124 (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
